Jul 21, 2008

Treatment of premature senility of the European study results

French National Health and Medical Research Institute and Nicolas Levy from Spain's Oviedo University School of Medicine Carlos Lopez - Aoting leadership of the research team found that in mice in the experiment, two existing elements statine (Used to lower cholesterol levels in the blood) and aminobisphosphonate (for the treatment of osteoporosis) of the compound to stop the toxic protein premature senility, and the incidence of premature senility is due to premature senility protein in the cells of the stock.

Of premature senility is a very rare disease, the sick children since birth will be infected. These children's appearance and physical deformities, as some of the old people: sparse hair, thin skin and no hair, joint stiffness, cardiovascular problems. Premature senility of Prior to this there is no treatment, the average life span of sick children are very short, only 12 years old to 13 years old.

The researchers believe that, in addition to the treatment of premature senility, these research results will also contribute to a better understanding of normal aging mechanism.

No comments: